News

January 27, 2017January 27, 2017

Kids with Asthma May Be at Higher Risk of Obesity, Researchers Say

Asthma, News

Children with asthma might be more prone to obesity later in childhood or in adolescence, a new study suggests. Researchers found that kindergarten-age children with asthma in southern California are 51 ... Read more

January 26, 2017January 26, 2017

Millions with Chronic Illnesses Benefited from ACA, but Many Still Left Without Coverage

COPD, News

While the Affordable Care Act (ACA) improved healthcare coverage for millions of Americans with chronic illnesses, many remained without coverage and faced barriers to getting regular medical care. This is ... Read more

January 25, 2017January 25, 2017

Opsumit Fails to Meet Primary Goal in Phase 3 Trial for PAH-Eisenmenger Syndrome

News, Pulmonary Hypertension

A Phase 3 trial assessing Actelion‘s Opsumit (macitentan) for the treatment of pulmonary arterial hypertension (PAH) due to Eisenmenger syndrome did not meet its primary objective of a change in exercise ... Read more

January 24, 2017January 24, 2017

FDA Grants Orphan Drug Status to Concert’s Cystic Fibrosis Therapy Candidate

Cystic Fibrosis, News

The U.S. Food and Drug Administration (FDA) has granted Orphan Drug designation to Concert Pharmaceuticals’ CTP-656 (deuterium-modified ivacaftor), a next generation CFTR (cystic fibrosis transmembrane conductance regulator) potentiator which is being developed for ... Read more

January 23, 2017January 23, 2017

One-third of Adults Diagnosed with Asthma Don’t Have the Disease, Canadian Study Finds

Asthma, News

A new research study revealed that 33 percent of adults in Canada who were diagnosed with asthma in the last five years do not have active asthma after all. The study, ... Read more

January 20, 2017January 20, 2017

PhaseBio’s $14.7M in Financing to Advance Therapy for PAH, Other Cardiopulmonary Disorders

News, Pulmonary Hypertension

PhaseBio Pharmaceuticals has closed on $14.7 million in financing to advance PB1046, its lead compound in clinical development, as a potential treatment of orphan cardiopulmonary disorders such as pulmonary arterial ... Read more

January 19, 2017January 19, 2017

New Removable Stent Shows Potential for Pulmonary Medicine

Lung Cancer, News

A new type of removable stent, created in 2015 for use in blood vessels, shows potential to also be used in the respiratory tract, which could transform treatment for patients who are ... Read more

January 18, 2017January 18, 2017

European Researchers Awarded €29M Grant to Assess RSV Lung Infections

Bronchiolitis, Emphysema, News, Pneumonia

Specialists in respiratory syncytial virus (RSV) from the RSV Consortium in Europe received a grant worth 29 million euro (equal to about $30.8 million American) to study serious lung infections caused ... Read more

January 17, 2017January 17, 2017

UK Inhaler Group to Present Data on Inhaled Therapies at Upcoming London Conference

Asthma, COPD, News

Key inhaler information, including compliance by patients with asthma and chronic obstructive pulmonary disease (COPD), along with educating patients and healthcare professionals (HCPs), will be one of the highlights of ... Read more

January 16, 2017January 16, 2017

Strategies Needed to Improve Adherence to COPD Medications, Study Says

COPD, News

Humana and Boehringer Ingelheim Pharmaceuticals have published a study showing that non-adherence to chronic obstructive pulmonary disease (COPD) medications is linked to non-adherence to medications for other chronic diseases. The ... Read more